Option chain shows key data for Scopus BioPharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Scopus BioPharma.

Scopus BioPharma (OTC:SCPS) Stock, Option Chain

Scopus BioPharma

Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. The company product candidates would utilize synthetically-produced cannabinoids as opposed to plant-derived compounds. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACMR

AEHR

ALVO

AMPX

ATNF

AVYA

BXRX

CACO

CENN

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

Core Scientific, Inc. - Class A Common Stock

CORZ

CVNA

DATS

EDSA

EVLV

GROM

GRRR

HLGN

HSDT

IMRN

LANV

LIPO

LWLG

MGAM

MLKN

OGEN

ORIC

OXBR

PBTS

PLXP

PRQR

RCKT

REKR

SAVA

SCPS

SINT

SOLO

Sunlight Financial Holdings, Inc. Class A Common Stock

SUNL

UIHC

VEDU

VERO

WEST

WETG

WISH

Gainers


	Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.


Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday&#39;s Mid-Day Session

ACLX

AGFY

AKLI

AKRO

ANEB

ANTE

APPH

ARBK

ARDX

ASPU

AXLA

BRDS

CCCC

CELC

CERE

CHPT

CINT

COEP

COSM

CZOO

DOMO

ETNB

FTFT

GEVO

GOSS

GREE

HCTI

HLTH

ICPT

IPDN

IPHA

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

MDGL

MHUA

MINM

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

MOND

MRSN

MULN

NEPT

NEWP

NEXA

NOGN

OBSV

OTIC

PERF

PHGE

PRFX

QUMU

RDIB

RELL

RLAY

SEER

SLNO

SMMT

SNPX

TELL

TERN

TRKA

VANI

VKTX

VTGN

ZVSA

Gainers


	Madrigal Pharmaceuticals, Inc.  (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.


Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday&#39;s Mid-Day Session

ADAG

ADBE

AGYS

ALLR

AMAM

AMEH

AUID

AUVI

BVXV

BYSI

CETX

CJJD

COIN

COMS

CRKN

DNUT

DRMA

New Oriental Education & Technology Group

Euda Health Holdings Limited - Ordinary Shares

EUDA

EXAS

FCUV

FFIE

ICVX

MAXR

MLGO

Morgan Stanley Capital Protected Notes for S&P 500 Index

NCRA

NVAX

PHIO

RCRT

SBET

SCHL

SPRY

STRY

STSS

TGTX

VLON

Gainers


	Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.


Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday&#39;s Mid-Day Session

SCOPUS BIOPHARMA INC by Scopus Biopharma, Inc.

Scopus BioPharma Inc

Despite his well-known disdain for cryptocurrencies, the &#8216;Oracle Of Omaha&#8217; &#8211; Warren Buffett&#8216;s Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) has invested in a company that supports the cryptocurrency market and has soared by 27.43% in 2024.
What Happened: Buffett&#8217;s Berkshire had <a href="https://www.benzinga.com/personal-finance/24/05/39093145/berkshire-hathaway-profits-f[%E2%80%A6]to-despite-warren-buffets-stance-on-not-buying-even-if-all-w">initially</a> invested $500 million in a Series G funding round and subsequently another $250 million in Nu Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>). 
Nu, a Brazilian digital banking company launched its cryptocurrency platform, Nubank Cripto, in 2022. Berkshire has since added 0.3% of this company&#8217;s shares in 18 months as of the quarter ended Sept. 30, 2024. 
Berkshire increased its holdings from 0.1% in the fourth quarter that ended Dec. 31, 2022, to 0.4% in the third quarter of fiscal 2025.
Initially supporting Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), and Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>), the platform, Nubank Cripto, now includes Uniswap (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/uni/usd">UNI</a>) and Chainlink (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/link/usd">LINK</a>). It allows users to send, receive, and convert cryptocurrencies, including stablecoins like USD Coin.
In 2018, during Berkshire Hathaway Inc.&#8217;s annual <a href="https://www.benzinga.com/general/24/03/37513063/warren-buffett-says-he-wouldnt-pay-25-for-all-the-bitcoin-in-the-world-he-considers-crypto-rat-poiso">shareholder</a> meeting, Buffett famously described Bitcoin as &#8220;probably rat poison squared&#8221;. On the contrary, Berkshire has profited substantially through its investment in Nu.
See Also: <a href="https://www.benzinga.com/25/01/42908280/intel-aims-for-cpu-market-share-growth-ai-breakthroughs-citi-reiterates-neutral-as-new-ceo-appointment-expected-in-coming-months">Intel Stock Has Fallen Over 58% In 1 Year, But Citi Maintains &#8216;Neutral&#8217; Rating On Expected Replacement Of Pat Gelsinger In A &#8216;Couple Of Months&#8217;</a> 
Why It Matters: According to its 13F filings, Berkshire held 86.438 million shares of Nu valued at $1.179 billion, as of the end of the third quarter.
With data for the fourth quarter not available at the time of writing, assuming that Berkshire&#8217;s holdings in Nu don&#8217;t change during this period, the value of these shares would have declined by 24.10% as of the quarter ended Dec. 31, when the share price was $10.36, as compared to $13.65 on Sept. 30, 2024.
However, Nu&#8217;s shares have risen by 27.43% in 2024, according to the data compiled by <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13074755/nu-in-2024-1024x576.png" alt="" class="wp-image-730370" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13074755/nu-in-2024-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13074755/nu-in-2024-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13074755/nu-in-2024-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13074755/nu-in-2024-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13074755/nu-in-2024.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
While Nu offers cryptocurrency services, one can argue in favor of Buffett that it&#8217;s not primarily a cryptocurrency company.
However, back in <a href="https://www.benzinga.com/general/24/03/37513063/warren-buffett-says-he-wouldnt-pay-25-for-all-the-bitcoin-in-the-world-he-considers-crypto-rat-poiso">2018</a>, Buffett also said &#8220;In terms of cryptocurrencies generally, I can say almost with certainty that they will come to a bad ending.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/01/42938954/michael-saylors-microstrategy-faces-risk-if-mstrs-0-convertible-bond-lenders-recall-non-recourse-loans-due-to-covenant-breach-heres-what-it-means-for-investors">Michael Saylor&#8217;s MicroStrategy Faces Risk If MSTR&#8217;s 0% Convertible Bond Lenders Recall Non-Recourse Loans Due To Covenant Breach: Here&#8217;s What It Means For Investors</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Financing

Management

$BTC

$ETH

$LINK

$MATIC

$UNI

LINK

Warren Buffett Openly Called Bitcoin A 'Rat Poison' In 2018. 7 Years Later, He Is Invested In This Crypto-Linked Stock Which Soared 27% In 2024

The crypto world is abuzz as&nbsp;Donald Trump&#8216;s new Solana-based (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) memecoin &#8220;OFFICIAL TRUMP&#8221; (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>), skyrocketed over 260% ahead of his inauguration on Jan. 20.
What Happened: Trump&#8217;s social media posts promoting the coin have sparked skepticism about the authenticity of the messages.
In a post on Saturday, Trump announced,&nbsp;"My NEW Official Trump Meme&nbsp;is HERE! It's time to&nbsp;celebrate everything we stand for:&nbsp;WINNING! Join my very special&nbsp;Trump Community. GET YOUR TRUMP&nbsp;NOW."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">My NEW Official Trump Meme is HERE! It's time to celebrate everything we stand for: WINNING! Join my very special Trump Community. GET YOUR <a href="https://twitter.com/search?q=%24TRUMP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TRUMP</a> NOW. Go to <a href="https://t.co/GX3ZxT5xyq">https://t.co/GX3ZxT5xyq</a> — Have Fun! <a href="https://t.co/flIKYyfBrC">pic.twitter.com/flIKYyfBrC</a>
&mdash; Donald J. Trump (@realDonaldTrump) <a href="https://twitter.com/realDonaldTrump/status/1880446012168249386?ref_src=twsrc%5Etfw">January 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The memecoin, trading at $23.20, reached&nbsp;a market capitalization of more than $4 billion, according <a href="https://coinmarketcap.com/dexscan/solana/A8nPhpCJqtqHdqUk35Uj9Hy2YsGXFkCZGuNwvkD3k7VC/">to</a> data from Coinmarketcap. 
Crypto trader&nbsp;Edward Morra&nbsp;predicted potential market sell-offs, while commentator&nbsp;Daniel Got Hits&nbsp;expressed skepticism despite sensing legitimacy. Analyst&nbsp;Will Clemente&nbsp;noted Solana&#8217;s price surge of 4.12%, reaching $228, as investors rushed to buy TRUMP.
Why It Matters: Trump's return to the White House has sparked speculation about his potential impact on the cryptocurrency market.
Reports indicate that Trump plans to issue&nbsp;<a href="https://www.benzinga.com/25/01/43073027/trump-plans-crypto-friendly-executive-orders-in-early-days-of-presidency-report">crypto-friendly executive orders</a>&nbsp;soon after taking office. These orders are expected to ease regulatory burdens on digital asset firms and promote cryptocurrency adoption.
Additionally, Trump is anticipated to establish a crypto advisory council, a concept he proposed earlier.
Moreover,&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43062997/exclusive-how-donald-trumps-crypto-plans-will-bitcoin-xrp-solana">experts are divided</a>&nbsp;on the likelihood of immediate executive actions, though many are optimistic about the short-term market outlook.
The potential for Trump to mention cryptocurrency during his inauguration speech is also being closely watched, with a&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43065423/donald-trump-to-mention-bitcoin-or-crypto-at-the-inauguration-polymarket-traders-say-theres-a-chance">31% chance</a>&nbsp;according to Polymarket traders.
Price Action: At the time of writing, TRUMP was trading at $23.20, gaining over 260% over the past 24 hours, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43073185/mark-zuckerberg-is-copying-elon-musks-playbook-amid-donald-trumps-comeback-but-chamath-palihapitiya-thinks-i">Mark Zuckerberg Is Copying Elon Musk&#8217;s Playbook Amid Donald Trump&#8217;s Comeback, But Chamath Palihapitiya Thinks It Is Opportunistic</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Politics

$SOL

$TRUMP

'Official Trump' Memecoin Jumps Over 260% Ahead Of President-Elect's White House Inauguration: Market Cap Reaches Whopping $4 Billion Within 8 Hours Of Launch

Chamath Palihapitiya weighed in on the actions of Mark Zuckerberg and Elon Musk amid the political resurgence of Donald Trump.
Palihapitiya suggests that while Musk&#8217;s decisions were driven by ethical considerations, Zuckerberg&#8217;s moves appear to be opportunistic.
What Happened: Palihapitiya remarked that Musk&#8217;s actions were made during a time when they were unpopular, indicating a moral stance rather than a focus on financial gain.
"Now the winds are blowing in a different direction, and I do think it&#8217;s the value-maximizing function," Palihapitiya said.
In contrast, he described Zuckerberg&#8217;s recent decisions as opportunistic, suggesting they align with the current favorable political climate following Trump&#8217;s victory in early November.
"Now that those winds have changed, and it&#8217;s clear Trump won in early November, the decisions you make in January are more reflective of the new conditions on the field coming into the inauguration."
Palihapitiya&#8217;s comments highlight a perceived shift in strategy by Zuckerberg, who seems to be adapting to the evolving political environment.
On the other hand, he believes Musk's decisions are geared towards maximizing benefits for humanity as a whole, rather than the shareholders of his companies.
"I don't think any other CEO leads this way. I do think Mark's a good person… Elon is different, and it creates an expectation that maybe we'll get that from everybody else," Palihapitiya added.
Why It Matters: This commentary comes in the wake of&nbsp;<a href="https://www.benzinga.com/news/25/01/42962037/elon-musk-urges-mark-zuckerberg-to-release-facebook-files-calls-it-good-after-meta-adopts-xs-communi">recent developments</a>&nbsp;where Musk urged Zuckerberg to release Meta&#8217;s content moderation communications with government officials.
This call for transparency followed Meta&#8217;s adoption of a Community Notes-like feature, which Musk supported.
The feature, however, will not <a href="https://www.benzinga.com/25/01/43047212/metas-community-notes-to-exempt-paid-ads-leaving-marketers-puzzled-about-organic-content-risks-report">apply to paid advertisements</a>, leaving marketers puzzled about organic content risks.
Additionally,&nbsp;Mark Zuckerberg&nbsp;recently praised former Meta COO&nbsp;Sheryl Sandberg&nbsp;amid criticism of Meta&#8217;s diversity, equity, and inclusion (DEI) program.
In a&nbsp;<a href="https://www.benzinga.com/25/01/43073009/mark-zuckerberg-lauds-sheryl-sandberg-amid-blame-for-metas-dei-program-she-did-amazing-work">post on Threads</a>, Zuckerberg commended Sandberg for her contributions, despite reports suggesting he blamed her for the DEI program&#8217;s shortcomings.
These actions and statements reflect the complex dynamics at play as tech leaders navigate the shifting political and social landscape.
The contrasting approaches of Musk and Zuckerberg underscore the varied motivations and strategies employed by influential figures in the tech industry.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="LA&#039;s Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland" width="500" height="281" src="https://www.youtube.com/embed/is1QAZ7ShRU?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43073056/tiktok-says-it-will-be-forced-to-go-dark-in-us-on-jan-19-after-supreme-court-upholds-ban">TikTok Says It Will Be &#8216;Forced To Go Dark&#8217; In US On Jan 19 After Supreme Court Upholds Ban</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

Tech

Mark Zuckerberg Is Copying Elon Musk's Playbook Amid Donald Trump's Comeback, But Chamath Palihapitiya Thinks It Is Opportunistic

On Friday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>), Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), and Ibotta Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>).
The Tempus AI Trade
Ark Invest&#8217;s Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) funds made substantial purchases of Tempus AI shares. The ARKG fund acquired 27,188 shares, while the ARKK fund bought a whopping 159,344 shares.
Based on the closing price of $35.15, the total value of these trades is approximately $6.57 million. This move aligns with Ark Invest&#8217;s <a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">recent trend of investing</a> in AI-driven companies.
The CRSP Trade
Ark Invest&#8217;s ARKG and ARKK funds also bought shares of CRISPR Therapeutics. The ARKG fund purchased 21,730 shares, while the ARKK fund added 125,690 shares.
Given the closing price of $40.53, the total value of these trades is approximately $5.96 million.
The PATH, RBLX, and RDDT Trades
On the other hand, Ark Invest sold shares of UiPath, Roblox, and Reddit. The ARKK fund offloaded 199,224 shares of UiPath, and 148,591 shares of Roblox, and the ARKW fund sold 5,215 shares of Reddit.
These sales indicate a shift in Ark Invest&#8217;s portfolio strategy.
Other Key Trades:
<ul>
<li>Ibotta Inc.: Ark Invest&#8217;s Ark Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) fund bought 4,364 shares of Ibotta.</li>
<li>Accolade Inc.: The ARKG fund sold 284,775 shares of Accolade.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In First 2 Weeks Of 2025</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Benzinga YouTube and Unsplash

ETFs

ACCD

ARKF

ARKG

ARKK

CRSP

IBTA

PATH

RBLX

RDDT

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia

Comments

Scopus BioPharma

Scopus BioPharma (SCPS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga